TY - JOUR
T1 - Introduction of negative charges to a crosslinked hemoglobin
T2 - Lack of effect on plasma half time
AU - Thomas, Michelle
AU - Matheson-Urbaitis, Barbara
AU - Kwansa, Herman
AU - Bucci, Enrico
AU - Fronticelli, Clara
N1 - Funding Information:
This work was supported in part by PHS grants RO1-HL-13164a nd Pol-HL-48517.D ifferential
PY - 1997
Y1 - 1997
N2 - Intramolecularly crosslinked hemoglobins do not dissociate into α1β1 dimers. As a result, they escape glomerular filtration and have plasma half times of 4 hours. This value is shorter than for albumin (5.2 hours) with similar molecular weight but higher negative charge. The present study was done to determine if increased negative charge on a hemoglobin covalently crosslinked with bis (3,5-dibromosalicyl) sebacate would lengthen its plasma half time. Negative charge was introduced by acylation with succinic anhydride. The product had a higher negative charge; however, plasma half time was not increased. A larger fraction of the succinylated material was excreted in the urine suggesting molecular instability.
AB - Intramolecularly crosslinked hemoglobins do not dissociate into α1β1 dimers. As a result, they escape glomerular filtration and have plasma half times of 4 hours. This value is shorter than for albumin (5.2 hours) with similar molecular weight but higher negative charge. The present study was done to determine if increased negative charge on a hemoglobin covalently crosslinked with bis (3,5-dibromosalicyl) sebacate would lengthen its plasma half time. Negative charge was introduced by acylation with succinic anhydride. The product had a higher negative charge; however, plasma half time was not increased. A larger fraction of the succinylated material was excreted in the urine suggesting molecular instability.
UR - http://www.scopus.com/inward/record.url?scp=0031148833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031148833&partnerID=8YFLogxK
U2 - 10.3109/10731199709118920
DO - 10.3109/10731199709118920
M3 - Article
C2 - 9167845
AN - SCOPUS:0031148833
SN - 2169-1401
VL - 25
SP - 309
EP - 314
JO - Biomaterials, Artificial Cells, and Immobilization Biotechnology
JF - Biomaterials, Artificial Cells, and Immobilization Biotechnology
IS - 3
ER -